These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 17035676)

  • 1. Phase II trial of pirfenidone in adults with neurofibromatosis type 1.
    Babovic-Vuksanovic D; Ballman K; Michels V; McGrann P; Lindor N; King B; Camp J; Micic V; Babovic N; Carrero X; Spinner R; O'Neill B
    Neurology; 2006 Nov; 67(10):1860-2. PubMed ID: 17035676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I trial of pirfenidone in children with neurofibromatosis 1 and plexiform neurofibromas.
    Babovic-Vuksanovic D; Widemann BC; Dombi E; Gillespie A; Wolters PL; Toledo-Tamula MA; O'Neill BP; Fox E; MacDonald T; Beck H; Packer RJ
    Pediatr Neurol; 2007 May; 36(5):293-300. PubMed ID: 17509460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trial of pirfenidone in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas.
    Widemann BC; Babovic-Vuksanovic D; Dombi E; Wolters PL; Goldman S; Martin S; Goodwin A; Goodspeed W; Kieran MW; Cohen B; Blaney SM; King A; Solomon J; Patronas N; Balis FM; Fox E; Steinberg SM; Packer RJ
    Pediatr Blood Cancer; 2014 Sep; 61(9):1598-602. PubMed ID: 24753394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response of NF1-related plexiform neurofibroma to high-dose carboplatin.
    Hummel T; Anyane-Yeboa A; Mo J; Towbin A; Weiss B
    Pediatr Blood Cancer; 2011 Mar; 56(3):488-90. PubMed ID: 21225936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antirheumatic effect of pirfenidone in a double blind clinical pilot trial in humans.
    Pesce E; Struma E; Giri SN; Margolin SB
    Res Commun Mol Pathol Pharmacol; 2004; 115-116():39-48. PubMed ID: 17564304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-alpha for neurofibromas.
    Kebudi R; Ayan I
    Med Pediatr Oncol; 1996 Mar; 26(3):220-2. PubMed ID: 8544807
    [No Abstract]   [Full Text] [Related]  

  • 7. [Nerve growth factor receptors on dissociated dermal and plexiform neurofibroma Schwann-like cells].
    Yasuda T; Sobue G; Mitsuma T
    Rinsho Shinkeigaku; 1987 Jul; 27(7):923-30. PubMed ID: 2822323
    [No Abstract]   [Full Text] [Related]  

  • 8. Whole body MR imaging in neurofibromatosis type 1.
    Van Meerbeeck SF; Verstraete KL; Janssens S; Mortier G
    Eur J Radiol; 2009 Feb; 69(2):236-42. PubMed ID: 19091504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical relevance of positron emission tomography and magnetic resonance imaging in the progression of internal plexiform neurofibroma in NF1.
    Mautner VF; Brenner W; Fünsterer C; Hagel C; Gawad K; Friedrich RE
    Anticancer Res; 2007; 27(4A):1819-22. PubMed ID: 17649778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial spinal neurofibromatosis.
    Pascual-Castroviejo I; Pascual-Pascual SI; Velazquez-Fragua R; Botella P; Viaño J
    Neuropediatrics; 2007 Apr; 38(2):105-8. PubMed ID: 17712740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase I clinical trial of the histone deacetylase inhibitor belinostat in patients with advanced hematological neoplasia.
    Gimsing P; Hansen M; Knudsen LM; Knoblauch P; Christensen IJ; Ooi CE; Buhl-Jensen P
    Eur J Haematol; 2008 Sep; 81(3):170-6. PubMed ID: 18510700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of insulin-like growth-factor-1 receptor (IGF-1R) in peripheral nerve sheath tumors in neurofibromatosis type 1.
    Friedrich RE; Keiner D; Hagel C
    Anticancer Res; 2007; 27(4A):2085-90. PubMed ID: 17649826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of axitinib in patients with advanced non-small-cell lung cancer: results from a phase II study.
    Schiller JH; Larson T; Ou SH; Limentani S; Sandler A; Vokes E; Kim S; Liau K; Bycott P; Olszanski AJ; von Pawel J
    J Clin Oncol; 2009 Aug; 27(23):3836-41. PubMed ID: 19597027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I dose escalation study of telatinib, a tyrosine kinase inhibitor of vascular endothelial growth factor receptor 2 and 3, platelet-derived growth factor receptor beta, and c-Kit, in patients with advanced or metastatic solid tumors.
    Eskens FA; Steeghs N; Verweij J; Bloem JL; Christensen O; van Doorn L; Ouwerkerk J; de Jonge MJ; Nortier JW; Kraetzschmar J; Rajagopalan P; Gelderblom H
    J Clin Oncol; 2009 Sep; 27(25):4169-76. PubMed ID: 19636022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurological complications involving the central nervous system in neurofibromatosis type 1.
    Hsieh HY; Wu T; Wang CJ; Chin SC; Chen YR
    Acta Neurol Taiwan; 2007 Jun; 16(2):68-73. PubMed ID: 17685129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tranilast: a novel preventor of neurofibroma growth?
    Namazi MR
    J Cosmet Dermatol; 2009 Jun; 8(2):146. PubMed ID: 19527340
    [No Abstract]   [Full Text] [Related]  

  • 17. Phase I clinical and pharmacokinetic study of kahalalide F administered weekly as a 1-hour infusion to patients with advanced solid tumors.
    Pardo B; Paz-Ares L; Tabernero J; Ciruelos E; García M; Salazar R; López A; Blanco M; Nieto A; Jimeno J; Izquierdo MA; Trigo JM
    Clin Cancer Res; 2008 Feb; 14(4):1116-23. PubMed ID: 18281545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trametinib therapy for children with neurofibromatosis type 1 and life-threatening plexiform neurofibroma or treatment-refractory low-grade glioma.
    Ronsley R; Hounjet CD; Cheng S; Rassekh SR; Duncan WJ; Dunham C; Gardiner J; Ghag A; Ludemann JP; Wensley D; Rehmus W; Sargent MA; Hukin J
    Cancer Med; 2021 Jun; 10(11):3556-3564. PubMed ID: 33939292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pathologic characteristics of the most frequent peripheral nerve tumors].
    Coulon A; Milin S; Laban E; Debiais C; Jamet C; Goujon JM
    Neurochirurgie; 2009 Oct; 55(4-5):454-8. PubMed ID: 19744677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of plexiform neurofibroma in neurofibromatosis type 1 in 18 family members of 3 generations: ultrasonography and magnetic resonance imaging a diagnostic supplement.
    Sehgal VN; Sharma S; Oberai R
    Int J Dermatol; 2009 Mar; 48(3):275-9. PubMed ID: 19261016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.